Literature DB >> 11335889

Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis.

Z Ostrowska1, B Kos-Kudla, E Swietochowska, B Marek, D Kajdaniuk, J Górski.   

Abstract

BACKGROUND: Lately, there have been suggestions that bone mass changes occurring in postmenopausal women may remain related to melatonin.
OBJECTIVE: To assess the relationship between the dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in ovariectomized rats--a model of postmenopausal osteoporosis.
METHODS: Mature Wistar female rats were either ovariectomozed or underwent a sham operation. Following this they were killed at 02:00AM at weekly intervals for 8 weeks after surgery. Serum levels of MEL at death related to the chosen biochemical markers of bone formation (alkaline phosphatase--ALP; carboxyterminal propeptide of type I procollagen--PICP, both in serum) and resorption (cross-linked carboxyterminal telopeptide of type I collagen--ICTP in serum; hydroxyproline--HYP and total calcium--Ca, both excreted in urine).
RESULTS: In all ovariectomized rats changes of examined indices of bone tissue metabolism were found to be dynamic and statistically significant relative to the control group; however the changes were more pronounced regarding resorption markers. Following ovariectomy, the increase in ALP and PICP values was found to begin at the 4th and the 1st week, while that in ICTP, HYP and Ca at the 2nd, the 1st and the 1st week, respectively. The ALP and PICP values remained at a similar level until the end of observation, whereas ICTP, HYP and Ca gradually decreased. MEL levels were decreased during the 2nd week following surgery and slightly increased 2 weeks later. The serum MEL levels in the ovariectomized group were significantly and negatively correlated with serum ICTP and both urinary HYP and Ca levels.
CONCLUSION: Our findings in rats seem to corroborate the concept of secondary changes in MEL levels co-participating in the development of bone mass changes characteristic for postmenopausal osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11335889

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  6 in total

Review 1.  Animal models for fracture treatment in osteoporosis.

Authors:  Marcus Egermann; J Goldhahn; E Schneider
Journal:  Osteoporos Int       Date:  2005-03-05       Impact factor: 4.507

2.  Nightshift work and fracture risk: the Nurses' Health Study.

Authors:  D Feskanich; S E Hankinson; E S Schernhammer
Journal:  Osteoporos Int       Date:  2008-09-03       Impact factor: 4.507

3.  Changes in vascularity of cartilage endplate of degenerated intervertebral discs in response to melatonin administration in rats.

Authors:  Mehmet Turgut; Serap Uslu; Ayşegül Uysal; Mine Ertem Yurtseven; Hatice Ustün
Journal:  Neurosurg Rev       Date:  2003-05       Impact factor: 3.042

4.  The effect of exogenous melatonin on reducing scoliotic curvature and improving bone quality in melatonin-deficient C57BL/6J mice.

Authors:  Hao Liu; Zhen Liu; Chi-Wai Man; Jing Guo; Xiao Han; Zongshan Hu; Tzi Bun Ng; Zhihui Zhao; Jie Li; Weijun Wang; Tseng-Chang Chun; Jun Qiao; Benlong Shi; Leilei Xu; Hongda Bao; Qing Jiang; Tsz Ping Lam; Jack Chun Yiu Cheng; Yong Qiu; Zezhang Zhu
Journal:  Sci Rep       Date:  2019-04-17       Impact factor: 4.379

5.  Melatonin prevents bone destruction in mice with retinoic acid-induced osteoporosis.

Authors:  Xudong Wang; Tongzhou Liang; Yuanxin Zhu; Jincheng Qiu; Xianjian Qiu; Chengjie Lian; Bo Gao; Yan Peng; Anjing Liang; Hang Zhou; Xiaoming Yang; Zhiheng Liao; Yongyong Li; Caixia Xu; Peiqiang Su; Dongsheng Huang
Journal:  Mol Med       Date:  2019-08-28       Impact factor: 6.354

6.  Melatonin increases bone mass in normal, perimenopausal, and postmenopausal osteoporotic rats via the promotion of osteogenesis.

Authors:  Huanshuai Guan; Ning Kong; Run Tian; Ruomu Cao; Guanzhi Liu; Yiyang Li; Qilu Wei; Ming Jiao; Yutian Lei; Fangze Xing; Peng Tian; Kunzheng Wang; Pei Yang
Journal:  J Transl Med       Date:  2022-03-16       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.